Recent News

• 09.09.2025 - REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference
• 09.09.2025 - REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference
• 09.08.2025 - Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System
• 09.08.2025 - Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System
• 08.20.2025 - Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications
• 08.20.2025 - Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications
• 08.05.2025 - Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities
• 08.05.2025 - Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

Recent Filings

• 09.09.2025 - EX-99.1 EX-99.1
• 09.09.2025 - 8-K Current report
• 09.08.2025 - 8-K Current report
• 09.08.2025 - EX-99.1 EX-99.1
• 08.27.2025 - 8-K Current report
• 08.25.2025 - 8-K Current report
• 08.20.2025 - EX-99.1 EX-99.1
• 08.20.2025 - 8-K Current report
• 08.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]